Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiwai Fanghua granules as adjunct to chemotherapy in non-small cell lung cancer
CTR20150551Phase 2Active
- Sponsor
- Guangdong Yikang Pharmaceutical
- Start
- Aug 2015
- Countries
- 1
01
Overview
A Phase 2 trial of Qiwai Fanghua granules in non-small cell lung cancer (NSCLC), sponsored by Guangdong Yikang Pharmaceutical. Started Aug 2015; status: active.
02
Drugs
Qiwai Fanghua granules
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20150551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150551.